Content overview
Quick product guide
Benefits
qPCR vs. dPCR
Contact and support
Products
Content
- Quick product guide
- Benefits
- qPCR vs. dPCR
- Contact and support
- Products
Accelerate delivery with confident VCN and RCL analysis
Reliable and rapid molecular safety testing is essential to advancing cell and gene therapies (CGTs). Our quantitative polymerase chain reaction (qPCR) and digital polymerase chain reaction (dPCR) assays for vector copy number (VCN) and replication-competent lentivirus (RCL) provide the sensitivity, specificity, and reproducibility necessary for confident decision-making throughout your CGT workflow.
Designed for in-process control (IPC), drug product release testing (RT), and effective drug monitoring and patient follow-up, these molecular assays provide the analytical rigor needed to meet regulatory expectations, protect patients, and accelerate your path to clinical and commercial manufacturing.
Content overview
Quick product guide
Benefits
qPCR vs. dPCR
Contact and support
Products
| Application | PCR method | Product |
| VCN assay | qPCR | MACS® qPCR COPYcheck Kit |
| dPCR | MACS® dPCR COPYcheck Kit, human | |
| RCL assay | qPCR | MACS® qPCR LENTIcheck Kit (VSV-G), human |
| dPCR | MACS® dPCR LENTIcheck Kit (VSV-G), human | |
| qPCR | MACS® qPCR LENTIcheck Kit (BaEV), human | |
| dPCR | MACS® dPCR LENTIcheck Kit (BaEV), human |
To ensure full coverage of lentiviral vectors used in manufacturing, RCL detection is available for both VSV-G (vesicular stomatitis virus glycoprotein) and BaEV (baboon envelope glycoprotein) gene sequences.
Designed and optimized for manufacturing control, our protocols and assays provide you with the accuracy and consistency you need to advance CGT programs with confidence.
Seamlessly integrate our assays into your workflow using detailed protocols for multiple platforms, streamlining operations and increasing efficiency.
Significantly shorten your validation timelines with expert training, ready-to-use analytical method validation plans, and tailored on-site guidance.
Quantitative PCR (qPCR) and digital PCR (dPCR) are essential analytical tools for CGT workflows. Both methods enable precise quantification of VCN and highly sensitive detection of RCL. While qPCR remains the industry standard for rapid, high-throughput testing, dPCR offers absolute quantification without standard curves and superior precision, particularly for low copy numbers.
Depending on your individual requirements, these technologies support robust, compliant, and scalable analytics throughout CGT development and manufacturing. Whether you need qPCR- or dPCR-based VCN and RCL assays, our COPYcheck and LENTIcheck solutions can support your CGT process. If you are unsure which assay is the best fit, connect with our experts or review the overview below.
Comparison qPCR and dPCR
| qPCR strengths | dPCR strengths |
| Well-established technology with extensive protocol availability | Emerging technology with strong fit for high sensitivity assays |
| Broad dynamic range for variable sample concentrations | Digital quantification allows for very high reproducibility |
| Fast, cost-effective instrumentation | Outstanding sensitivity for low copy number detection |
| High throughput with automation options | Absolute quantification without standard curves |
These products are intended for use with lentiviral vectors provided by Miltenyi Bioindustry – a division of Miltenyi Biotec. For compatibility with additional vector systems, please get in touch with Miltenyi Biotec Technical Support.
6 products found
|
You have previously chosen International as your location.
What do you want to do?